Afuresertib, also known as GSK2110183, is an orally bioavailable inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity.
For research use only. We do not sell to patients.
Name | Afuresertib HCl |
---|---|
Iupac Chemical Name | (S)-N-(1-Amino-3-(3-fluorophenyl)propan-2-YL)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-YL)thiophene-2-carboxamide hydrochloride |
Synonyms | GSK2110183; GSK 2110183; GSK-2110183; GSK2110183B; GSK 2110183B; GSK2110183B; Afuresertib |
Molecular Formula | C18H18Cl3FN4OS |
Molecular Weight | 463.78 |
Smile | Cl.NC[C@H](CC1=CC(=CC=C1)F)NC(=O)C=1SC(=C(C1)C1=C(C=NN1C)Cl)Cl |
InChiKey | YFQJOPFTGMHYNV-YDALLXLXSA-N |
InChi | InChI=1S/C18H17Cl2FN4OS.ClH/c1-25-16(14(19)9-23-25)13-7-15(27-17(13)20)18(26)24-12(8-22)6-10-3-2-4-11(21)5-10;/h2-5,7,9,12H,6,8,22H2,1H3,(H,24,26);1H/t12-;/m0./s1 |
CAS Number | 1047645-82-8 |
Related CAS | 1047645-82-8 |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Crystalline solid |
---|---|
Purity | ≧98.0% |
Storage | 3 years -20ºCpowder |
Solubility | Soluble in DMSO |
Handling | Refer to MSDS |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |